Novolog (Type 2 Diabetes)：市場予測と分析（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 8
1.2 List of Figures 8
2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 10
3 Disease Overview 13
3.1 Etiology and Pathophysiology 13
3.1.1 Etiology 13
3.1.2 Pathophysiology 14
3.1.3 Prognosis 15
3.1.4 Quality of Life 16
3.2 Symptoms 16
4 Disease Management 18
4.1 Treatment Overview 18
4.1.1 Diagnosis and Referrals 18
4.1.2 Treatment Guidelines 19
5 Competitive Assessment 25
5.1 Overview 25
5.2 Strategic Competitor Assessment 26
6 Novolog/NovoRapid (insulin aspart) 28
6.1 Overview 28
6.2 Efficacy 29
6.3 Safety 29
6.4 SWOT Analysis 29
6.5 Forecast 30
7 Appendix 31
7.1 Bibliography 31
7.2 Abbreviations 34
7.3 Methodology 35
7.4 Forecasting Methodology 35
7.4.1 Diagnosed Type 2 Patients 35
7.4.2 Percent Drug-Treated Patients 36
7.4.3 Drugs Included in Each Therapeutic Class 36
7.4.4 Launch and Patent Expiry Dates 37
7.4.5 General Pricing Assumptions 37
7.4.6 Individual Drug Assumptions 38
7.4.7 Generic Erosion 38
7.5 Physicians and Specialists Included in this Study 39
7.6 About the Authors 41
7.6.1 Analyst II – CVMD 41
7.6.2 Therapy Director – CVMD and Infectious Disease 41
7.6.3 Global Head of Healthcare 42
7.7 About GlobalData 43
7.8 Disclaimer 43